Therapeutic Asset Ratings
227 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Axatilimab
Breast-Ovarian Cancer, Familial, Susceptibility To, 1
Dana-Farber Cancer Institute
P1
CC
(41)
Axatilimab
BRCA2-Related Cancer Predisposition
Dana-Farber Cancer Institute
P1
CC
(41)
Calcium folinate pentahydrate
Brain Cancer
Dana-Farber Cancer Institute
P1
CC
(41)
Ciml-Nk Cells
Myeloproliferative Neoplasm
Dana-Farber Cancer Institute
P1
CC
(41)
Cytokine Induced Memory-Like Natural Killer Cells
Myeloid Leukemia
Dana-Farber Cancer Institute
P1
CC
(41)
Cytokine Induced Memory-Like Natural Killer Cells
Myeloproliferative Neoplasm
Dana-Farber Cancer Institute
P1
CC
(41)
Cytokine-Induced Memory-Like Natural Killer Cells
Myeloid Leukemia
Dana-Farber Cancer Institute
P1
CC
(41)
Cytokine-Induced Memory-Like Natural Killer Cells
Ovarian Carcinoma
Dana-Farber Cancer Institute
P1
CC
(41)
Cytokine-Induced Memory-Like Natural Killer Cells
Ovarian Cancer
Dana-Farber Cancer Institute
P1
CC
(41)
FLUOROURACILUM
Brain Cancer
Dana-Farber Cancer Institute
P1
CC
(41)
mk-3475
Brain Cancer
Dana-Farber Cancer Institute
P1
CC
(41)
Neovax
Cutaneous Melanoma
Dana-Farber Cancer Institute
P1
CC
(41)
Panobinostat
Breast Cancer Stage III
Dana-Farber Cancer Institute
P1
CC
(41)
Recombinant Human Interleukin-2
Leukemia, Myeloid
Dana-Farber Cancer Institute
P1
CC
(41)
Rqnestin
Brain Cancer
Dana-Farber Cancer Institute
P1
CC
(41)
Rqnestin
Brain Neoplasm
Dana-Farber Cancer Institute
P1
CC
(41)
Tazemetostat
Breast Cancer Stage III
Dana-Farber Cancer Institute
P1
CC
(41)
Venetoclax
Breast Cancer Stage III
Dana-Farber Cancer Institute
P1
CC
(41)
Donor T Cells
Myelodysplastic Syndromes
Dana-Farber Cancer Institute
P2
CC
(40)
asp8374
Glioblastoma
Dana-Farber Cancer Institute
P1
CC
(40)
Panobinostat
Triple Negative Breast Cancer
Dana-Farber Cancer Institute
P1
CC
(40)
Aguix
Non-Small Cell Lung Carcinoma
Dana-Farber Cancer Institute
P1/2
CC
(40)
Ipilimumab
Myelofibrosis
Dana-Farber Cancer Institute
P1
C
(39)
Neovax
Metastatic Melanoma
Dana-Farber Cancer Institute
P1
C
(39)
Rqnestin
Glioma
Dana-Farber Cancer Institute
P1
C
(39)
Showing 176 to 200 of 227 assets
Previous
Page 8 of 10
Next